Enorama Pharma AB (publ) (STO:ERMA)
Sweden · Delayed Price · Currency is SEK 0.6800
-0.0200 (-2.86%)
Sep 25, 2026, 12:38 PM CET
Enorama Pharma AB Market Cap
Enorama Pharma AB has a market cap or net worth of 52.21 million as of September 24, 2026. Its market cap has decreased by -73.48% in one year.
Market Cap
52.21M
Enterprise Value
50.11M
Revenue
1.45M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.68
ChartMarket Cap Chart
Since June 10, 2016, Enorama Pharma AB's market cap has increased from 35.83M to 52.21M, an increase of 45.74%. That is a compound annual growth rate of 3.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 52.21M | -63.35% |
| Dec 30, 2025 | 142.46M | -29.89% |
| Dec 30, 2024 | 203.19M | 77.51% |
| Dec 29, 2023 | 114.47M | 308.04% |
| Dec 30, 2022 | 28.05M | -83.60% |
| Dec 30, 2021 | 171.01M | -12.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nanexa AB | 1.03B |
| Dicot Pharma AB | 780.46M |
| EQL Pharma AB | 685.09M |
| Cinclus Pharma Holding AB | 546.35M |
| Moberg Pharma AB | 514.27M |
| Orexo AB | 440.01M |
| Enzymatica AB | 412.65M |
| Klaria Pharma Holding AB (publ.) | 145.62M |